Drugs / Generex Oral-lyn™
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00668850 | Apr 2008 → Aug 2011 | diabetes mellitus | Generex Biotechnology Corp. | Unknown | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT00948493 | — | type 1 diabetes mellitus, type 2 diabetes mellitus | Generex Biotechnology Corp. | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Generex Oral-lyn | “Treatment Use of Generex Oral-lyn™ in Patients With Diabetes” NCT00948493 ↗ |
| Route | Oral | “oral spray insulin (Generex Oral-lyn™)” NCT00668850 ↗ |